Summary
It is known that natural killer (NK) cells are involved in immunosurveillance against tumours. This study examines the NK activity of mononuclear cells (MNC) from the peripheral blood of patients with gliobalstoma. The cytotoxic inducer effect of interferonalpha (IFN-α) upon these MNC has also been studied. A marked decrease in NK activity mediated by MNC from these patients was found. This functional defected in MNC is not due to a decrease in phenotypically defined NK cells. After long-term (5-day) incubation with IFN-α, MNC from 5 out of 14 patients showed strong lytic activity against NK-sensitive target cells. In this system, IFN-α failed to induce cytotoxic activity against NK-resistant target cells in MNC from all the patients studied. Thisin vitro induction of cytotoxic activity in MNC from some patients with glioblastoma by IFN-α suggests a potential immunotherapeutic use of the lymphokine in these subjects.
Similar content being viewed by others
References
Alvarez de Mon M, Casas J, Laguna R, Jordá J, Durántez A (1987) Clinical signification of natural killer activity in B cell chronic lymphocytic leukemia. Eur J Haematol 38: 268–273
Barlozzi T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW (1985) Direct evidence for the role of NK cells in the inhibition of tumour metastasis. J Immunol 134: 2783–2789
Boyum A (1968) Separation of leukocytes from blood and bone marrow. Scan J Clin Lab Invest [Suppl] 21, vol 97: 72–83
Braun DP, Penn RD, Harris JE (1984) Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies. Neurosurgery 15: 29–33
Carballido J, Alvarez-Mon M, Solovera J, Menéndez-Ondina L, Durántez A (1990) Clinical signification of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol 143: 29–33
de la Hera A, Alvarez-Mon M, Sánchez-Madrid F, Martinez AC, Durántez A (1989) Coexpression of Mac-1 and p 150, 95 on CD5+ cells. Structural and functional characterization in a human chronic lymphocytic leukemia (B-CLL). Eur J Immunol 18: 1131–1134
Gleave JRW (1985) Surgery for primary brain tumors. In: Bleehen NM (ed) Tumors of the brain. Springer, Berlin Heidelberg New York Tokyo, pp 101–120
Herberman RB, Ortaldo JR (1981) Natural killer cells. Their role in defenses against disease. Science 214: 24–30
Itoh K, Tilden AB, Balch CM (1986) Lysis of human solid tumor cells by lymphokine activated natural killer cells. J Immunol 136: 3910–3915
Kadish AS, Doyle AT, Steinhauer EH, Ghossein NA (1981) Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J Immunol 127: 1817–1822
Lanier LL, Lee AM, Philips JH, Warker WL, Babcock GF (1983) Subpopulations of human natural killer cells defined by the expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 131: 1789–1796
Salcman M (1985) Supratentorial gliomas: clinical features and surgical therapy. In: Wilkins RH, Rengachari SS (eds) Neurosurgery. McGraw-Hill Book Co, New York, pp 579–590
Timonen T, Ortaldo JR, Herberman RB (1982) Analysis by a single cell cytotoxicity assay of natural killer (NK) cell frequencies among human large granular lymphocytes and the effects of interferon on their activity. J Immunol 128: 2514–2519
Vaquero J, Martinez R (1988) Glioma supratentorial. In: Vaquero J (ed) Neurologia quirúrgica. Alpe Ed, Madrid, pp 199–212
Vaquero J, Martínez R, Oya S, Coca S, Barbolla L, Ramiro J, Salazar FG (1989) Intratumoral injection of autologous lymphocytes plus human lymphoblastoid interferon for the treatment of glioblastoma. Acta Neurochir (Wien) 98: 35–41
Walker MD, Alexander E Jr, Hunt HE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrel HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333–343
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lapeña, P., Isasi, C., Vaquero, J. et al. Modulation by interferon alpha of the decreased natural killer activity in patients with glioblastoma. Acta neurochir 109, 109–113 (1991). https://doi.org/10.1007/BF01403004
Issue Date:
DOI: https://doi.org/10.1007/BF01403004